Schizophrenia Research
Volume 84, Issue 2 , Pages 204-213 , June 2006

Protein expression profiling of postmortem brain in schizophrenia

  • Jianfeng Mei

      Affiliations

    • Ciphergen Biosystems, Inc., 6611 Dumbarton Circle, Fremont, CA 94555, United States
    • Present Address: Department of Pharmacology, Yale University School of Medicine, 333 Cedar Street, P.O. 208066, New Haven, CT 06520-8066, United States.
    • ,
  • Daniel Kolbin

      Affiliations

    • Nathan Kline Institute for Psychiatric Research and Department of Psychiatry, New York University School of Medicine, 140 Old Orangeburg Road, Orangeburg, NY 10962, United States
    • ,
  • Hung-Teh Kao

      Affiliations

    • Nathan Kline Institute for Psychiatric Research and Department of Psychiatry, New York University School of Medicine, 140 Old Orangeburg Road, Orangeburg, NY 10962, United States
    • Present Address: B. Porton and H.-T. Kao contributed equally to this work.
    • ,
  • Barbara Porton

      Affiliations

    • Nathan Kline Institute for Psychiatric Research and Department of Psychiatry, New York University School of Medicine, 140 Old Orangeburg Road, Orangeburg, NY 10962, United States
    • Present Address: B. Porton and H.-T. Kao contributed equally to this work.
    • Corresponding Author InformationCorresponding author. Tel.: +1 845 398 2070; fax: +1 845 398 5422.

Received 7 December 2005 ,Revised 15 February 2006 ,Accepted 17 February 2006.

References 

  1. Andreasen NC, Carpenter WT. Diagnosis and classification of schizophrenia. Schizophr. Bull. 1993;19:199–214
  2. Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL, et al. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet. 1997;349:1730–1734
  3. Edgar PF, Schonberger SJ, Dean B, Faull RL, Kydd R, Cooper GJ. A comparative proteome analysis of hippocampal tissue from schizophrenic and Alzheimer's disease individuals. Mol. Psychiatry. 1999;4:173–178
  4. Edgar PF, Douglas JE, Cooper GJ, Dean B, Kydd R, Faull RL. Comparative proteome analysis of the hippocampus implicates chromosome 6q in schizophrenia. Mol. Psychiatry. 2000;5:85–90
  5. Fountoulakis M, Hardmeier R, Höger H, Lubec G. Postmortem changes in the level of brain proteins. Exp. Neurol. 2001;167:86–94
  6. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Arch. Gen. Psychiatry. 1999;55:537–547
  7. Grizzle WE, Semmes OJ, Basler J, Izbicka E, Feng Z, Kagan J, et al. The Early Detection Research Network surface-enhanced laser desorption and ionization prostate cancer detection study: a study in biomarker validation in genitourinary oncology. Urol. Oncol. 2004;22:337–343
  8. Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 2001;98:4746–4751
  9. Harrison PJ. The neuropathology of schizophrenia. A critical review of the data and their interpretation. Brain Res. 1999;122:593–624
  10. Johann DJ, McGuigan MD, Patel AR, Tomov S, Ross S, Conrads TP, et al. Clinical proteomics and biomarker discovery. Ann. N. Y. Acad. Sci. 2004;1022:295–305
  11. Johnston-Wilson NL, Sims CD, Hofmann J-P, Anderson L, Shore AD, Torrey EF, et al. Disease-specific alterations in frontal cortex brain proteins in schizophrenia, bipolar disorder, and major depressive disorder. Mol. Psychiatry. 2000;5:142–149
  12. Knable MB, Torrey EF, Webster MJ, Bartko JJ. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res. Bull. 2001;55:651–659
  13. McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, et al. MRI anatomy of schizophrenia. Biol. Psychiatry. 1999;45:1099–1119
  14. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53–67
  15. Park S, Holzman PS. Schizophrenics show spatial working memory deficits. Arch. Gen. Psychiatry. 1992;49:975–982
  16. Park S, Holzman PS. Association of working memory deficit and eye tracking dysfunction in schizophrenia. Schizophr. Res. 1993;11:55–61
  17. Petricoin EF, Ardekani AM, Hitt BA, Levine PJ, Fusaro VA, Steinberg SM, et al. Use of proteomic patterns in serum to identify ovarian cancer. Lancet. 2002;359:572–577
  18. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JT, Griffin JL, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol. Psychiatry. 2004;9:684–697
  19. Qu Y, Adam B-L, Yasui Y, Ward MD, Cazares LH, Schellhammer PF, et al. Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. Clin. Chem. 2002;48:1835–1843
  20. Rajkowska G, Selemon LD, Goldman-Rakic PS. Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry. 1998;55:215–224
  21. Sanfilipo M, Lafargue T, Rusinek H, Arena L, Loneragan C, Lautin A, et al. Volumetric measure of the frontal and temporal lobe regions in schizophrenia: relationship to negative symptoms. Arch. Gen. Psychiatry. 2000;57:471–480
  22. Semmes OJ, Feng Z, Adam BL, Banez LL, Bigbee WL, Campos D, et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin. Chem. 2005;51:102–112
  23. Simon R. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data. Br. J. Cancer. 2003;89:1599–1604
  24. Swatton JE, Prabakaran S, Karp NA, Lilley KS, Bahn S. Protein profiling of human postmortem brain using 2-dimensional fluorescence difference gel electrophoresis (2-D DIGE). Mol. Psychiatry. 2004;9:128–143
  25. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and Neuropathology Consortium. Schizophr. Res. 2000;44:151–155
  26. Tsuang MT. Heterogeneity of schizophrenia. Biol. Psychiatry. 1975;10:465–474
  27. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr. Res. 2002;58:11–20
  28. Velligan DI, Bow-Thomas CC. Executive function in schizophrenia. Semin. Clin. Neuropsychiatry. 1999;4:24–33
  29. Vlahou A, Schorge JO, Gregory BW, Coleman RL. Diagnosis of ovarian cancer using decision tree classification of mass spectral data. J. Biomed. Biotechnol. 2003;5
  30. Wang Z, Yip C, Ying Y, Wang J, Meng XY, Lomas L, et al. Mass spectrometric analysis of protein markers for ovarian cancer. Clin. Chem. 2004;50:1939–1942
  31. Wang H, Qian WJ, Chin MH, Petyuk VA, Barry RC, Liu T, et al. Characterization of the mouse brain proteome using global proteomic analysis complemented with cysteinyl-peptide enrichment. J. Proteome Res. 2006;5:361–369
  32. Weinberger DR, Berman KF. Prefrontal function in schizophrenia: confounds and controversies. Philos. Trans. R. Soc. Lond., B Biol. Sci. 1996;351:1495–1503
  33. Weinberger SR, Dalmasso EA, Fung ET. Current achievements using ProteinChip® Array technology. Curr. Opin. Chem. Biol. 2001;6:86–91
  34. Yang S-y, Xiao X-y, Zhang W-g, Zhang L-j, Zhang W, Zhou B, et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer. 2005;5:83
  35. Zhang Z, Bast RC, Yu Y, Li J, Sokoll LJ, Rai AJ, et al. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer. Cancer Res. 2004;64:5882–5890

PII: S0920-9964(06)00084-3

doi: 10.1016/j.schres.2006.02.016

Schizophrenia Research
Volume 84, Issue 2 , Pages 204-213 , June 2006

Article Tools

* Image Usage & Resolution